Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BREDBALLE FYSIOTERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   4.1% 4.0% 2.2% 5.1% 6.1% 6.0% 10.7% 10.7%   Credit score (0-100)   51 51 66 42 38 38 23 23   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,390 2,544 2,645 1,791 207 680 0.0 0.0   EBITDA   436 421 446 -32.8 58.2 245 0.0 0.0   EBIT   108 93.1 227 -263 -170 17.5 0.0 0.0   Pre-tax profit (PTP)   43.4 74.4 202.2 -307.8 -192.0 -47.7 0.0 0.0   Net earnings   32.9 58.0 157.6 -240.3 -150.4 -37.8 0.0 0.0   Pre-tax profit without non-rec. items   43.4 74.4 202 -308 -192 -47.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   399 261 251 211 173 135 0.0 0.0   Shareholders equity total   252 310 467 227 76.7 38.8 -11.2 -11.2   Interest-bearing liabilities   1,355 2,805 2,293 2,484 2,463 2,714 218 218   Balance sheet total (assets)   2,012 3,647 3,416 2,834 2,591 2,904 207 207   Net Debt   1,347 2,803 2,289 2,484 2,463 2,714 218 218     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,390 2,544 2,645 1,791 207 680 0.0 0.0   Gross profit growth   9.8% 6.5% 4.0% -32.3% -88.5% 229.2% -100.0% 0.0%   Employees   4 5 6 4 1 1 0 0   Employee growth %   0.0% 25.0% 20.0% -33.3% -75.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,012 3,647 3,416 2,834 2,591 2,904 207 207   Balance sheet change%   -12.1% 81.3% -6.3% -17.1% -8.6% 12.1% -92.9% 0.0%   Added value   108.2 93.1 226.9 -263.1 -169.6 17.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -656 -656 -419 -461 -456 -456 -135 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 -2.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   4.5% 3.7% 8.6% -14.7% -82.0% 2.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   5.0% 4.5% 8.4% -6.0% -3.4% 3.7% 0.0% 0.0%   ROI %   5.9% 5.3% 9.8% -6.7% -3.5% 3.8% 0.0% 0.0%   ROE %   14.0% 20.6% 40.5% -69.2% -99.0% -65.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   12.5% 8.5% 13.7% 8.0% 3.0% 1.3% -5.1% -5.1%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   308.8% 665.5% 513.6% -7,575.1% 4,231.3% 1,106.6% 0.0% 0.0%   Gearing %   538.1% 905.5% 490.5% 1,093.8% 3,212.8% 6,988.5% -1,951.5% -1,951.5%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.2% 2.6% 3.8% 5.0% 4.0% 5.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 1.7 2.4 1.9 2.1 2.3 0.0 0.0   Current Ratio   0.5 1.8 2.4 1.9 2.1 2.3 0.0 0.0   Cash and cash equivalent   8.1 2.7 3.3 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -418.9 1,058.4 1,372.6 965.1 1,035.5 1,252.3 -108.9 -108.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   27 19 38 -66 -170 17 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   109 84 74 -8 58 245 0 0   EBIT / employee   27 19 38 -66 -170 17 0 0   Net earnings / employee   8 12 26 -60 -150 -38 0 0